Company profile
Ticker
AEON, AEON-WT
Exchange
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
Former names
Priveterra Acquisition Corp.
SEC CIK
Corporate docs
Subsidiaries
AEON Biopharma Sub, Inc. ...
IRS number
853940478
AEON stock data
Latest filings (excl ownership)
8-K
AEON Biopharma, Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
7 Feb 25
DEF 14A
Definitive proxy
23 Jan 25
PRE 14A
Preliminary proxy
13 Jan 25
8-K
AEON Biopharma, Inc. Announces Pricing of Approximately $20.0 Million Underwritten Public Offering
7 Jan 25
424B5
Prospectus supplement for primary offering
7 Jan 25
8-K
AEON Biopharma, Inc. Announces Pricing of Approximately $20.0 Million Underwritten Public Offering
6 Jan 25
424B5
Prospectus supplement for primary offering
6 Jan 25
8-K
Amendments to Articles of Incorporation or Bylaws
20 Dec 24
424B3
Prospectus supplement
13 Nov 24
10-Q
2024 Q3
Quarterly report
13 Nov 24
Latest ownership filings
SC 13G/A
Blue Owl Capital Holdings LP
14 Feb 25
SC 13G/A
Polar Asset Management Partners Inc.
14 Feb 25
SC 13D
PALMISANO ROBERT J
22 Jan 25
SC 13G
S.H.N. Financial Investments Ltd.
13 Jan 25
SC 13G
L1 Capital Global Opportunities Master Fund, Ltd.
13 Jan 25
SC 13G
BIGGER CAPITAL FUND L P
8 Jan 25
SC 13G
Blue Owl Capital Holdings LP
14 Nov 24
4/A
ROBERT J PALMISANO
10 Sep 24
4
Marc Forth
4 Sep 24
4
Alexander Blair Wilson
4 Sep 24
Financial summary
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | |||
---|---|---|---|---|---|---|
Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q | |
Cash on hand (at last report) | 537.00 k | 537.00 k | 537.00 k | 537.00 k | 537.00 k | 537.00 k |
Cash burn (monthly) | 968.33 k | 385.08 k | 2.06 mm | (no burn) | 985.00 k | 2.56 mm |
Cash used (since last report) | 4.54 mm | 1.80 mm | 9.63 mm | n/a | 4.61 mm | 11.98 mm |
Cash remaining | -4.00 mm | -1.27 mm | -9.10 mm | n/a | -4.08 mm | -11.44 mm |
Runway (months of cash) | -4.1 | -3.3 | -4.4 | n/a | -4.1 | -4.5 |
Institutional ownership, Q3 2024
4.9% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 17 |
Opened positions | 8 |
Closed positions | 17 |
Increased positions | 3 |
Reduced positions | 1 |
13F shares | Current |
---|---|
Total value | 2.02 bn |
Total shares | 3.94 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Strathspey Crown | 2.03 mm | $14.26 mm |
Vanguard | 751.34 k | $788.91 mm |
Formidable Asset Management | 389.78 k | $409.27 mm |
BlackRock | 265.15 k | $278.41 mm |
Geode Capital Management | 243.17 k | $255.37 mm |
CAPROCK | 62.69 k | $65.82 mm |
NTRS Northern Trust | 51.93 k | $54.53 mm |
LMR Partners | 48.90 k | $51.35 mm |
LPL Financial | 26.84 k | $28.18 mm |
Cutter & CO Brokerage | 14.03 k | $14.73 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
31 Aug 24 | Palmisano Robert J | Class A Common Stock | Grant | Acquire A | No | No | 0 | 36,021 | 0.00 | 36,021 |
31 Aug 24 | Palmisano Robert J | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 0.83 | 96,210 | 79.85 k | 96,210 |
31 Aug 24 | Shelley B Thunen | Class A Common Stock | Grant | Acquire A | No | No | 0 | 36,021 | 0.00 | 36,021 |
31 Aug 24 | Shelley B Thunen | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 0.83 | 96,210 | 79.85 k | 96,210 |
31 Aug 24 | Chad Oh | Class A Common Stock | Grant | Acquire A | No | No | 0 | 192,117 | 0.00 | 292,545 |
31 Aug 24 | Chad Oh | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 0.83 | 512,673 | 425.52 k | 512,673 |
31 Aug 24 | Marc Forth | Class A Common Stock | Grant | Acquire A | No | No | 0 | 470,692 | 0.00 | 750,547 |
31 Aug 24 | Marc Forth | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 0.83 | 1,256,062 | 1.04 mm | 1,256,062 |
31 Aug 24 | Alexander Blair Wilson | Class A Common Stock | Grant | Acquire A | No | No | 0 | 180,110 | 0.00 | 261,538 |
31 Aug 24 | Alexander Blair Wilson | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 0.83 | 480,631 | 398.92 k | 480,631 |
News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
4w ago
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
4w ago
12 Health Care Stocks Moving In Friday's Pre-Market Session
1mo ago
Dow Jumps Over 300 Points; US Industrial Production Beats Estimates
1mo ago
Why Taiwan Semiconductor Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
1mo ago